Regulatory cell therapy for kidney transplantation and autoimmune kidney diseases.

ABSTRACT: Regulatory cell therapies, including regulatory T cells and mesenchymal stromal cells, have shown promise in early clinical trials for reducing immunosuppression burden in transplantation. While regulatory cell therapies may also offer potential for treating autoimmune kidney diseases, data remains sparse, limited mainly to preclinical studies. This review synthesises current literature on the application of regulatory cell therapies in these fields, highlighting the safety and efficacy shown in existing clinical trials. We discuss the need for further clinical validation, optimisation of clinical and immune monitoring protocols, and the challenges of manufacturing and quality control under Good Manufacturing Practice conditions, particularly for investigator-led trials. Additionally, we e

SUBMITTER: Ho QY 

PROVIDER: S-EPMC11584488 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature